Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03755076 · ClinicalTrials.gov registry record · Early Phase 1

Perceptual-motor Interaction to Improve Bimanual Coordination After Stroke

A Early Phase 1 study of Stroke, sponsored by Albert Einstein Healthcare Network.

Completed
Registry status
Early Phase 1
Development phase
79
Enrollment target
1
Study location

NCT03755076: Completed Early Phase 1 study of Stroke, sponsored by Albert Einstein Healthcare Network.

NCT03755076 is a Early Phase 1 study of Stroke that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 79 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03755076, a Early Phase 1 study of Stroke, has completed, sponsored by Albert Einstein Healthcare Network.

COMPLETED
Registry status
Early Phase 1
Development phase
79 participants
Enrollment target
1
Study location

Study Summary

Significant difficulty in incorporating the weaker arm in daily activities after stroke is, in part, driven by difficulty in engaging both arms interactively in a coordinated manner. The current study aims to determine the nature of bimanual coordination deficits after stroke and takes initial steps to test a novel theory-driven approach to improve interactive bimanual coordination in patients with stroke. This project will advance stroke rehabilitation by identifying novel, scientifically-based strategies to improve the engagement of the weaker arm in coordinated and interactive bimanual actions of daily life, thus improving quality of life in individuals after stroke.

Primary Outcome

Cross-correlation between tangential velocity profiles of the two hands was used to index spatial and temporal coordination between hands. Cross-correlation measures similarities of two distinct time series as a function of the displacement of one relative to the other. Repeated correlations between the two hand velocity profiles were obtained as the velocity profile of one hand was successively lagged. The maximum cross correlation coefficient obtained gave a measure of similarity between the t

Conditions Studied

Interventions

  • BEHAVIORAL Perceptual cuing

Study Locations (1)

Pennsylvania

  • Moss Rehabilitation Research Institute - Elkins Park

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2019-04-19
Est. Completion 2024-01-03
Phase Early Phase 1
Albert Einstein Healthcare Network

48 total trials

What the finished NCT03755076 record still lists

NCT03755076 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Perceptual cuing is the first listed.

NCT03755076 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03755076 about?

NCT03755076 is a clinical study titled "Perceptual-motor Interaction to Improve Bimanual Coordination After Stroke". Significant difficulty in incorporating the weaker arm in daily activities after stroke is, in part, driven by difficulty in engaging both arms interactively in a coordinated manner. The current study aims to determine the nature of bimanual coordination deficits after stroke and takes initial step...

What is the current status of trial NCT03755076?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 79 participants. The study started on 2019-04-19. Estimated completion is 2024-01-03.

What conditions does trial NCT03755076 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT03755076?

The interventions under investigation include: Perceptual cuing (BEHAVIORAL).

Who is sponsoring clinical trial NCT03755076?

This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03755076 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03755076's enrollment target sits among peer trials

79 174th of 454 higher than 281 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05798897 · 79 participants · Phase 1

    Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • NCT06042439 · 79 participants · NA

    AM vs PM Exercise Training

  • NCT06223555 · 79 participants · NA

    Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03755076, the US trial registry maintained by the National Library of Medicine. NCT03755076 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.